Alzheimer’s Small-Molecule Therapy Shows Promise in Mice and Early Human Trial

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 14 Oct, 18:00 UTC

A small-molecule therapy, VG-3927, targeting microglial TREM2 signaling showed neuroprotective effects in preclinical studies for Alzheimer's disease and was well tolerated in a Phase I trial. The post Alzheimer’s Small-Molecule Therapy Shows Promise in Mice and Early Human Trial appeared first on…

science

Sources

• T2Alzheimer’s Small-Molecule Therapy Shows Promise in Mice and Early Human TrialFierce Biotech / Fierce Healthcare / MedCity / GEN14 Oct, 18:00